Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

Comment by DanGSstockson May 05, 2021 4:03pm
144 Views
Post# 33134191

RE:RE:RE:RE:RE:RE:RE:RE:GE has 40% of the ultrasound market and will direct

RE:RE:RE:RE:RE:RE:RE:RE:GE has 40% of the ultrasound market and will directHi GrahamB

The product that VPT has is a work station which does all the necessary calculations using data coming from the ultrasound and convert it into 3D image + sound (3D or 4D depending on the actual ultrasound) that can directly be visualized, manipulated, measured and compared to say half-a-year old images to highlight disease progression/healing.  Think of it as a computer that gets hooked up to any given ultrasound machine. 

So yes, GE wants to use VMS3+ as add on to their ultrasounds and it gives them an edge for the next little while, as they are the only ones that offer this duo. Ultrasounds get outdated or broken all the time, there is huge market for them and is not going anywhere within our trading careers. :-)

If you listen to George's description, it took his team a while to adopt their platform to GE's ultrasounds.  Not that I fully understand, but likely it's like different operating systems on different manufacturer’s ultrasound machines.  The output has to be understood by the VMS3 platform. Having said this, the VPT team can do the installation remotely, meaning they already did all the compatibility troubleshooting.

So, the model that George talks about is the same. Sell or lease models. I'm hoping that leasing would preferred by the customers as it is a higher recurring revenue = higher MC and earlier retirement for us investors.

 
GLTA 
<< Previous
Bullboard Posts
Next >>